Litcius/Paper detail

Olaparib Combined with Abiraterone versus Olaparib Monotherapy for Patients with Metastatic Castration-resistant Prostate Cancer Progressing after Abiraterone and Harboring DNA Damage Repair Deficiency: A Multicenter Real-world Study

Jun Xie, Hanxu Guo, Baijun Dong, Wei Chen, Chengqi Jin, Qiufan Xu, Li Ding, Wujianhong Liu, Shengrong Dong, Tingting Zhao, Yang Yu, Changcheng Guo, Xudong Yao, Bo Peng, Bin Yang

2024European Urology Oncology11 citationsDOI

Topics & Concepts

OlaparibAbirateroneMedicineProstate cancerOncologyAbiraterone acetateInternal medicineAndrogen deprivation therapyCancerPoly ADP ribose polymeraseDNAAndrogen receptorBiologyPolymeraseGeneticsProstate Cancer Treatment and ResearchPARP inhibition in cancer therapyProstate Cancer Diagnosis and Treatment
Olaparib Combined with Abiraterone versus Olaparib Monotherapy for Patients with Metastatic Castration-resistant Prostate Cancer Progressing after Abiraterone and Harboring DNA Damage Repair Deficiency: A Multicenter Real-world Study | Litcius